SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001562884-21-000024
Filing Date
2021-08-17
Accepted
2021-08-17 07:38:49
Documents
13
Period of Report
2021-08-16
Confirming Copy
 
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING nunz-20210816.htm   iXBRL 8-K 18130
  Complete submission text file 0001562884-21-000024.txt   142721

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nunz-20210816_def.xml EX-101.DEF 1857
3 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nunz-20210816_lab.xml EX-101.LAB 13281
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nunz-20210816_pre.xml EX-101.PRE 8606
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nunz-20210816.xsd EX-101.SCH 21775
6 EXTRACTED XBRL INSTANCE DOCUMENT nunz-20210816_htm.xml XML 2347
Mailing Address 1627 WEST 14TH STREET LONG BEACH CA 90813
Business Address 1627 WEST 14TH STREET LONG BEACH CA 90813 714-609-9117
NUNZIA PHARMACEUTICAL Co (Filer) CIK: 0000886093 (see all company filings)

IRS No.: 870442090 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39175
SIC: 8741 Services-Management Services
Office of Trade & Services